Altered post-translational modifications, such as tau hyper-phosphorylation or α-tubulin deacetylation, may disrupt microtubule assembly and cytoskeleton-based cargo trafficking, contributing to PD pathogenesis [26]. The gene discussed is MAPT; the disease is Parkinson disease.